CompletedNCT02073240
Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and Thailand
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centers for Disease Control and Prevention
- Principal Investigator
- Michele L Pearson, MDCenters for Disease Control and Prevention, Center for Global Health, Division of Global HIV and TB
- Intervention
- Enhanced TB IC Package(behavioral)
- Enrollment
- 22 enrolled
- Eligibility
- 18-45 years · All sexes
- Timeline
- 2014 – 2016
Study locations (22)
- Buddhasothorn Hospital, Maruphong, Cha Cherng Sao, Thailand
- Chaiyaphum Hosptial, Nai Mueang, Changwat Chaiyaphum, Thailand
- Nakhon Nayok Hospital, Mueang Nakhonnayok, Changwat Nakhon Nayok, Thailand
- Nan Hospital, Nai Wiang, Mueang Nan, Changwat Nan, Thailand
- Chao Phraya Abhaibhubejhr Hosptial, Mueang Prachinburi, Changwat Prachin Buri, Thailand
- Banpong Hospital, Ban Pong, Changwat Ratchaburi, Thailand
- Singburi Hospital, Mueang Singburi, Changwat Sing Buri, Thailand
- Chumponkhetudomsak Hospital, Mueang, Chumpon, Thailand
- Pichit Hospital, Nai Mueang, Pichit, Thailand
- Praputtabat Hosptial, Changwat Sara Buri, Praputtabat, Thailand
- Hai Duong TB Hospital, Hải Dương, Hai Duong, Vietnam
- Binh Phuoc General Hospital, Bình Phước, Vietnam
- Dong Thap TB Hospial, Dong Thập, Vietnam
- Hoa Binh General Hospital, Hòa Bình, Vietnam
- Hung Yen Provincial Hospital, Hưng Yên, Vietnam
- +7 more locations on ClinicalTrials.gov
Collaborators
United States President's Emergency Plan for AIDS Relief
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02073240 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- RECRUITINGNCT07451899TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung DiseaseUniversitas Padjadjaran
- RECRUITINGNCT06845618Blood Tuberculosis DNA Levels to Monitor Tuberculosis TreatmentUniversity of Oxford
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet